CHICAGO, Sept. 15, 2011 /PRNewswire/ -- ICAP Patent Brokerage, a division of ICAP plc and the world's largest intellectual property and patent auction firm, today announced that it will offer a Covenant Not to Sue (CNS) from Boadin Technology, LLC ("Boadin Technology") at its upcoming CNS Auction September 27th in Los Angeles. The CNS is a perpetual covenant not to sue for all of the patents and pending patent applications in the current patent portfolio owned by Boadin Technology. The portfolio consists of 12 patents and pending patent applications protecting various content presentation related technologies.
Boadin Technology is currently engaged in patent litigation with a number of companies as follows:
The New York Times Company
Fox News Network, LLC
Dow Jones & Company, Inc.
Gannett Co., Inc.
The patents asserted in that litigation are U.S. Patent No. 7,856,472 and U.S. Patent No. 7,849,148.
A CNS is an agreement that prevents assertion of a party's right to litigation. A company entering into a CNS with respect to the Boadin Technology patents would gain the freedom to operate under Boadin Technology's patents, and would avoid the uncertainty inherent in patent infringement litigation.
Starting today, ICAP Patent Brokerage will accept anonymous bids on the Boadin Technology CNS. To learn more about the assets available or to place a bid, contact Kevin Fiur at Kevin.Fiur@us.icap.com or (512) 505-2308.
About ICAP Patent Brokerage
ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.
About Boadin Technology, LLC
Boadin Technology, LLC is a Delaware company dedicated to the acquisition and licensing of patented technology.
SOURCE ICAP Patent Brokerage